At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 71 enrolled
Drug / intervention
Ketorolac +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Oral Ketorolac for Pain Relief During IUD Insertion: A Randomized Controlled Trial
In Brief
A Phase 4 clinical trial evaluating Ketorolac and Placebo for Contraception. Completed, enrolled 71 participants.
Detailed Summary
Ketorolac is a non-steroidal anti-inflammatory drug (NSAID), similar to ibuprofen but it is used to treat more severe pain. Ketorolac (Trade name: Toradol) is typically used after surgical procedures. When taken orally, it should not cause sedation. The purpose of this study is to determine if oral ketorolac is effective at reducing pain during IUD placement versus a placebo tablet.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsContraception
Countries--
Collaborators--
Timeline
Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartJul 2014
Primary CompletionMar 2016
First PostedJan 2017
TodayJul 2026
First PostedJan 26, 2017
Enrollment StartJul 1, 2014
Primary CompletionMar 1, 2016
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 9.4 years ago
Interventions
Ketorolacdrug
Oral Tablet
Placebodrug
Oral Tablet